What is it about?

This article describes the validation and verification procedures for point of care high-sensitivity troponin assays and outlines what should be the responsibility of the manufacturers and provides recommendations on how a local verification may be undertaken before instruments are implemented into routine clinical practice.

Featured Image

Read the Original

This page is a summary of: Considerations and pragmatic strategies for implementation of point of care testing for high sensitivity cardiac troponin into the acute care setting, Clinical Chemistry and Laboratory Medicine (CCLM), March 2026, De Gruyter,
DOI: 10.1515/cclm-2026-0210.
You can read the full text:

Read

Contributors

The following have contributed to this page